期刊文献+

上颌牙槽突外伤性缺损即刻修复临床研究

Immediate restoration with bone composite in exognathion defect
下载PDF
导出
摘要 目的探讨应用骨复合材料即刻修复上颔牙槽突外伤性缺损的可行性。方法选取我院收治的40例上颌牙槽突外伤性缺损患者,采用传统方法治疗20例(对照组),改良方法(以复合材料修复)治疗20例(改良组),术后3个月分别对两组患者行牙槽嵴吸收严重程度临床评判及相应上颔牙槽突高度X线检查,并作对比分析。结果术后3个月,对照组患者均出现牙槽嵴明显吸收,而改良组仅3例出现明显吸收,余17例轻度吸收,对照组牙槽嵴明显吸收发生率显著高于改良组(X^2=26.2,P〈0.01);对照组相应上颔牙槽突高度为(095±013)mm,改良组为(15.9±0.32)mm,对照组相应上颌牙槽突高度显著低于改良组(t=3.26,P〈0.01)。结论应用骨复合材料即刻修复上颌牙槽突外伤性缺损疗效明显优于传统方法,能明显改善对上颌牙槽骨骨量的保留。 Objective To evaluate the feasibility of immediate restoration in exognathion defect with bone composite material. Methods Forty patients with maxillary alveolar process defect were enrolled in the study, 20 were treated by conventional methods as controls, other 20 treated by modified methods with bone composite material. The height of alveolar process were analyzed and compared between two groups 3 months later. Results The rate of absorption in alveolar process of control group was higher than that of modified group (20/20 vs 3/20, X^2= 26.2, P〈0.01).Spiral CT examination showed that the height of alveolar process in modified group was higher than that in control group (1.59±0.32mm vs 0.95±0.13mm, t=3.26, P〈0.01). Conclusion The modified method with bone composite demonstrates the better results in immediate restoration of maxillary alveolar process defect.
出处 《浙江医学》 CAS 2009年第8期1076-1078,共3页 Zhejiang Medical Journal
基金 折江省医药卫生科学研究基金(2006B125).
关键词 上颌牙槽突缺损 即刻修复 骨复合材料 异体脱细胞真皮基质补片 Exognathion defect Immediate restoration The bone composite Acellular allogeneic dermal matrix
  • 相关文献

参考文献4

二级参考文献40

  • 1许建中.骨组织工程临床研究现状与展望[J].组织工程与重建外科杂志,2007,3(2):61-64. 被引量:2
  • 2Kawamuna M, Teixido J, Laiho N et al. Chondroosteogenetic reponse to crude bone matrix proteins bound to hydroxyapatite.Clin Orthop, 1990, 217:281.
  • 3Oakes D A, Lee C C, Lieberman J R. An evaluation of human demineralized bone matrices in a rat femoral defect model. Clin Orthop, 2003, 281:290.
  • 4Edwards J T, Diegmann M H, Scarborough N L. Osteoinduction of human demineralized bone: characterization in a rat model.Clin Orthop, 1998, 357:219.
  • 5Wang J C, Kanim L E, Nagakawa I S et al. Dose-dependent toxicity of a commercially available demineralized bone matrix material. Spine, 2001, 26:1429.
  • 6Langstaff S, Sayer M, Smith T J et al. Resorbable bioceramics based on stabilized calcium phosphates. Part Ⅰ: rational design,sample preparation and material characterization. J Biomaterial,1999, 20:1727.
  • 7Courts R D, Healey R M, Ostrander R. Tissue engineering,cells, scaffolds, and growth factors: matrices for cartilage repair. Clin Orthop, 2001, 391 ( Suppl): S271.
  • 8Eckart H, Bundgaard K G, Christensen K S et al. Effects of locally applied vascular endothelial growth factor (VEGF) and VEGF-inhibitor to the rabbit tibia during distraction osteogenesis. J Orthop Res, 2003, 21:335.
  • 9Mauney JR,Jaquiery C,Volloch V,et al.In vitro and in vivo evaluation of differentially demineralized cancellous bone scaffolds combined with human bone marrow stromal cells for tissue engineering.Biomaterials,2005,26(16):3173-3185.
  • 10Kiberstis P,Smith O,Norman C.Tissue Engineers Build New Bone,Science,2000,289(1):1498-1500.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部